Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE

on

  • 414 views

ENDOMETRIAL CARCINOMA

ENDOMETRIAL CARCINOMA

Statistics

Views

Total Views
414
Views on SlideShare
414
Embed Views
0

Actions

Likes
0
Downloads
61
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE Presentation Transcript

  • 1. SHRUTHI.S.JAYARAJ,53 RD CALICUT MEDICAL COLLEGE
  • 2. DEVELOPED COUNTRIES DEVELOPING COUNTRIES CA ENDOMETRIUM CA CERVIX  POOR HYGEINE MULTIPARITY EARLY MARRIAGE
  • 3.  INCIDENCE IS HIGHEST IN U.S, LOWEST IN INDIA, JAPAN  PRIMARILY IN POST MENOPAUSAL LADIES MEAN AGE ~ 60 yrs
  • 4. OESTROGEN RISK FACTORS OTHERS OBESITY DIABETES HYPERTENSION HNPCC
  • 5.  EXOGENOUS HORMONE REPLACEMENT THERAPY  TAMOXIFEN FOR BREAST CANCER ENDOGENOUS EARLY MENARCHE LATE MENOPAUSE PCOS OBESITY FUNCTIONING OVARIAN TUMORS
  • 6.  HORMONE THERAPY FOR POST MENOPAUSAL LADIES : ‘FEMININE FOREVER’ !!! OESTROGEN USED ALONE OESTROGEN + PROGESTINS RISK RISK
  • 7.  SERM  POTENT ANTAGONIST IN BREAST – Rx of CA BREAST PARTIAL AGONIST IN UTERUS LONG TERM USE- ENDOMETRIAL PROLIFERATION,CARCINOMA
  • 8.  COMBINED ORAL HORMONAL PILLS HAVE A PROTECTIVE EFFECT AND REDUSES RISK BY 4050%
  • 9.  OBESITY REDUCES LEVEL OF SERUM HORMONE BINDING PROTEIN FREE ESTROGEN CIRCULATES IN BODY  PERIPHERAL FAT : CONVERSION OF EPIANDROSTENEDIONE TO OESTRONE
  • 10.  NULLIPAROUS WOMEN & WOMEN WITH PCOD NON OVULATION HIGH OESTROGEN ENDOMETRIAL HYPERPLASIA ENDOMETRIAL CANCER
  • 11. NULLIPARITY PCOS EARLY MENARCHE LATE MENOPAUSE TAMOXIFEN HRT RISK FACTORS OBESITY DIABETES HYPERTENSION LYNCH 2 / HNPCC
  • 12.  WOMEN WITH FAMILIAL LYNCH 2 SYNDROME (HNPCC) ARE LIKELY TO SUFFER FROM ENDOMETRIAL CANCER.
  • 13.  TYPE 1  TYPE 2
  • 14. TYPE 1  WELL DIFFERENCIATED  GLANDS BACK TO BACK  MINIMUM STROMA
  • 15. TYPE 2  POORLY DIFFERENCIATED  PREDOMINANTLY SOLID PATTERN  MINIMAL GLAND FORMATION
  • 16. 55-65 YRS OESTROGEN DEPENDANT PREVIOUS H/O EXPOSURE TO UNOPPOSED OESTROGEN. a/w OBESITY/HYPERTENSION/DIABETES ‘WELL DIFFERENCIATED’ & MIMICS PROLIFERATIVE ENDOMETRIAL GLANDS.AS SUCH,REFERRED TO AS ENDOMETRIOD CARCINOMA EXCELLENT PROGNOSIS
  • 17. 65 – 75 yrs OESTROGEN INDEPENDENT UNRELATED TO HORMONE EXPOSURE USUALLY ARISES IN AN ATROPHIC ENDOMETRIUM USUALLY UNDIFFERENCIATED & AGGRESSIVE DEEP MUSCLE INVASION BAD PROGNOSIS
  • 18. TYPE 1 TYPE 2  55-65 YRS  65 – 75 YRS  ESTROGEN  ESTROGEN DEPENDENT  ENDOMETRIAL HYPERPLASIA MAY BE PRESENT  WELL DIFFERENCIATED INDEPENDENT  USUALLY IN ATROPHIC ENDOMETRIUM  UNDIFFERENCIATED
  • 19. TYPE 1 TYPE 2  STABLE  AGGRESSIVE  MINIMAL MUSCLE  DEEP MUSCLE INVASION  HISTOLOGY – ENDOMETRIOD  EXCELLENT PROGNOSIS INVASION  HISTOLOGY- SEROUS / CLEAR CELL  BAD PROGNOSIS
  • 20.  ENDOMETRIAL CANCER MAY BE : LOCALISED/ DIFFUSE APPEAR AS : NODULE POLYP DIFFUSE LESION INVOLVING WHOLE UTERINE CAVITY
  • 21. DIFFUSE
  • 22.  TO THE NAKED EYE THE ENDOMETRIAL CURETTINGS APPEAR PALE & FRIABLE  HISTOLOGICALLY 75 % ADENOCARCINOMA REST- SQUAMOUS / SEROUS
  • 23. GRADE 1 : WELL DIFFERENCIATED ADENO CARCINOMA < 5 % SOLID GROWTH PATTERN GRADE 2 : MODERATELY DIFFERENCIATED ADENOCARCINOMA 6 – 50 % SOLID GROWTH PATTERN GRADE 3 : POORLY DIFFERENCIATED ADENOCARCINOMA > 50 % SOLID GROWTH PATTERN
  • 24. GRADE 1 GRADE 2 GRADE 3
  • 25.  ENDOMETRIOD  MUCINOUS  PAPILLARY SEROUS  CLEAR CELL  SQUAMOUS  UNDIFFERENCIATED  MIXED
  • 26.  ENDOMETRIOD GOOD PROGNOSIS  MUCINOUS  PAPILLARY SEROUS  CLEAR CELL  SQUAMOUS BADPROGNOSIS
  • 27.  COMMONEST TYPE ~ 80 %  COMPOSED OF GLANDS WHICH RESEMBLE NORMAL ENDOMETRIAL GLANDS  WELL DIFFERENCIATED & GOOD PROGNOSIS
  • 28.  5 % OF CANCERS  HAVE A MUCINOUS PATTERN  WELL DIFFERENCIATED GLANDULAR PATTERN  GOOD PROGNOSIS
  • 29.  5 % ALL TUMORS  EXHIBIT PAPILLARY PATTERN  BEHAVE AGGRESSIVELY  POOR PROGNOSIS  HIGH RISK FOR LYMPHOVASCULAR SPACE INVOLVEMENT AND DEEP MYOMETRIAL INVASION EVEN WITH EARLY STAGE DISEASE  SPREAD EARLY TO ABDOMEN
  • 30.  5 % OF ALL CANCERS  CELLS LARGE WITH ATYPICAL NUCLEI,CLEAR CYTOPLASM, CONTAIN GLYCOGEN  MAY SHOW HOBNAIL CONFIGURATION AND FORM PAPILLARY STRUCTURES  HIGHLY AGGRESSIVE  BAD PROGNOSIS
  • 31. A B c
  • 32.  VERY RARE VARIETY  R/O SPREAD FROM CERVICAL SQUAMOUS EPITHELIUM  VERY POOR PROGNOSIS EVEN WITH STAGE 1 DISEASE
  • 33. CLINICAL FEATURES
  • 34.  ASYMPTOMATIC IN 7- 10 %  MANIFEST AS MENORRHAGIA & IRREGULAR PERIODS PERIMENOPAUSAL LADIES POST MENOPAUSAL BLEEDING IN MENOPAUSAL WOMAN
  • 35. ELDERLY WITH CERVICAL STENOSIS HAEMATOMETRA/PYOMETRA PURULENT VAGINAL DISCHARGE
  • 36.  SOME WOMEN EXPERIENCE PELVIC PRESSURE AND PAIN DUE TO UTERUS ENLARGEMENT OR EXTRAUTERINE SPREAD
  • 37.  ADVANCED STAGE- BULKY CERVIX, GROWTH PROTRUDING THROUGH OS
  • 38. THANK YOU